# US 11,318,160 B2 · Composition and methods for generating and sustaining molecular hydrogen (H2) in aqueous systems

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 11,318,160 B2
- Document ID: US11318160B2
- Status: Granted
- Kind: B2
- Application number: 16/736,749
- Filed: 2020-01-07
- Published: 2020-07-02
- Granted: 2022-05-03
- Earliest claimed: 2018-07-23
- Assignees: Nutragenom, LLC
- Applicants: Nutragenom, LLC
- Inventors: Eugene P. Pittz
- Web page: https://patentgrep.com/patent/US11318160B2

## CPC

- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- C08L 5/00: Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- A01K 61/13: Prevention or treatment of fish diseases
- A01K 63/042: {Introducing gases into the water, e.g. aerators, air pumps}
- A23G 1/426: {containing vitamins or antibiotics}
- A23L 2/39: Dry compositions
- A23L 19/09: {Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks (A23L19/01, A23L19/10, A23L27/63 and A23L21/00 take precedence)}
- A23L 23/00: Soups; Sauces (soya sauce A23L27/50; salad dressings, mayonnaise or ketchup A23L27/60); Preparation or treatment thereof
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 47/02: Inorganic compounds
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/12: Carboxylic acids; Salts or anhydrides thereof
- A61K 47/38: Cellulose; Derivatives thereof
- C08K 3/08: Metals
- C08L 5/14: Hemicellulose; Derivatives thereof
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A23G: COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- C08K: Use of inorganic or non-macromolecular organic substances as compounding ingredients (paints, inks, varnishes, dyes, polishes, adhesives C09)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

Provided are compositions, methods, and solutions for generating aqueous glucomannan solutions with hydrogen compositions greater than 100 parts per billion. Said glucomannan solutions have application in nutritional, therapeutic, and energy fields.

## Claims

### Claim 1

A glucomannan solution comprising a concentration of glucomannan and an initial concentration of hydrogen (H2), and comprising an organic acid, wherein the organic acid is selected from the list consisting of citric acid, malic acid, lactic acid, acetic acid, tartaric acid, succinic acid, phosphoric acid or any combination thereof, wherein upon exposure of the glucomannan solution to Imperial Units standard temperature and pressure (STP) for 240 minutes, the glucomannan solution comprises a second H2 concentration which is at least about 70% of the initial H2 concentration as measured in parts per billion (ppb), further comprising a base metal which is magnesium metal powder.

### Claim 2 (depends on 1)

The glucomannan solution of claim 1, wherein the initial hydrogen (H2) is present at a concentration of greater than about 100 ppb (parts per billion) hydrogen (H2) at Imperial Units Standard Temperature and Pressure (STP).

### Claim 3 (depends on 1)

The glucomannan solution of claim 1, wherein the volume of the glucomannan solution is at least 0.01%, at least 0.1%, at least 1%, at least 10%, or at least 20% greater than the volume of a corresponding glucomannan solution which does not comprise H2.

### Claim 4 (depends on 1)

The glucomannan solution of claim 1, wherein the glucomannan concentration is from about 0.00001% to about 7.5%.

### Claim 5 (depends on 1)

The glucomannan solution of claim 1, wherein the solution is a gel.

### Claim 6 (depends on 1)

The glucomannan solution of claim 1, wherein the solution is a flowable liquid.

### Claim 7 (depends on 1)

The glucomannan solution of claim 1, wherein the H2 is present in a gaseous form.

### Claim 8 (depends on 1)

The glucomannan solution of claim 1, wherein, upon exposure of the glucomannan solution to Imperial Units Standard Temperature and Pressure (STP) for 240 minutes, the concentration of hydrogen in the glucomannan solution declines by less than 1%, less than 5%, less than 10%, less than 15%, less than 20%, less than 25%, or less than 30% as measured in parts per billion (ppb).

### Claim 9 (depends on 1)

The glucomannan solution of claim 1, further comprising an additional base metal.

### Claim 10 (depends on 9)

The glucomannan solution of claim 9, further comprising an additional base metal selected from the group consisting of lithium, potassium, strontium, calcium, sodium, aluminum, zinc, chromium, manganese, iron, and any combination thereof.

### Claim 11 (depends on 1)

The glucomannan solution of claim 1, wherein the magnesium metal powder is present in the glucomannan solution in an amount from about 0.00001% w/v to about 2% w/v.

### Claim 12 (depends on 1)

The glucomannan solution of claim 1, wherein the citric acid is present in an amount from about 0.1% w/v to about 15% w/v.

### Claim 13 (depends on 1)

The glucomannan solution of claim 1, wherein the malic acid is present in an amount from about 1% (w/v) to about 50% w/v.

### Claim 14 (depends on 1)

The glucomannan solution of claim 1, wherein the lactic acid is present in an amount from about 1% w/v to about 10% w/v.

### Claim 15 (depends on 1)

The glucomannan solution of claim 1, wherein the solution is an aqueous solution.

### Claim 16

An H2-generating composition comprising:
lactic acid;
glucomannan;
magnesium metal powder;
glycerin; and
an aqueous solvent,
wherein the composition comprises an initial concentration of hydrogen (H2) wherein upon exposure of the composition to Imperial Units standard temperature and pressure for 240 minutes, the composition comprises a second H2 concentration which is at least about 70% of the initial H2concentration as measured in parts per billion (ppb).

### Claim 17 (depends on 16)

The composition of claim 16, wherein the composition is a cream, gel, foam, ointment, lotion, or liquid.
